Views
4 years ago

99 - JP Díaz - Agosto 2016

  • Text
  • Diaz
  • Disfuncion
  • Toc
  • Glutamatergicos
  • Moduladores
  • Psico
  • Pediatric
  • Rosenberg
  • Glutamato
  • Disorder
  • Trastornos
  • Tratamiento
  • Pacientes
  • Psychiatry
Hipótesis glutamatérgica en el TOC: hallazgos neurobiológicos y moduladores glutamatérgicos

Dr. Juan Pablo

Dr. Juan Pablo Díaz OJ, Liang, KY, Hoehn-Saric, R, Cullen, B, Grados, M, Beaty, TH, Shugart, YY. Complex segregation analysis provides compelling evidence for a major gene underlying obsessive-compulsive disorder and for heterogeneity by sex. Am J Hum Genet, 2000; 67: 1611–6 • Nestadt, G, Samuels, J, Riddle, MA, Liang, KY, Bienvenu, OJ, Hoehn-Saric, R, Grados, M, Cullen, B. The relationship between obsessive-compulsive disorder and anxiety and affective disorders: results from the Johns Hopkins OCD Family Study. Psychol Med,2001; 31:481–7. • Nestadt, G, Samuels, JF, Riddle, MA, Bienvenu, OJ, Liang, K-Y, Grados, MA, Cullen, B. Obsessive-compulsive disorder: defining the phenotype. J Clin Psychiatry, 2002; 63 Suppl 6: 5–7. • Orrego, F, Villanueva, S. The chemical nature of the main central excitatory transmitter: a critical appraisal base dupon release studies and synaptic vesicle localization. Neuroscience, 1993; 56: 539–55. • Parent, A, Hazrati, LN. Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop. Brain Res Rev, 1995; 20: 91–127. • Pauls, DL. The genetics of obsessive compulsive disorder: are view of the evidence. Am J Med Genet C Semin Med Genet, 2008; 148C: 133–9. • Pallanti S., Grassi G., Cantisani A., 2014. Emerging drugs to treat obsessive-compulsive disorder. Expert Opin Emerg Drugs. 2014 Mar;19(1):67-77. • Piras, F, Caltagirone, C, Spalletta, G. Brain circuitries of obsessive compulsive disorder: a systematic review and meta-analysis of diffusion tensor imaging studies. Neurosci Biobehav Rev, 2013a; 37:2856–77. • Piras, F, Chiapponi, C, Girardi,P ,Caltagirone, C, Spalletta, G. Widespread structural brain changes in OCD: A systematic review of voxel-based morphometry studies. Cortex, 2013b; 62C: 89–108. • Pooley, EC, Fineberg, N, Harrison, PJ. The met (158) allele of catechol-Methyltransferase (COMT) is associated with obsessive-compulsive disorder in men: casecontrol study and meta-analysis. Mol Psychiatry, 2007; 12: 556–61. • Radua, J, Mataix-Cols, D. Voxel-wise meta-analysis of grey matter changes in obsessive-compulsive disorder. Br J Psychiatry, 2009; 195: 393–402. • Radua, J, vandenHeuvel, OA, Surguladze, S, Mataix- Cols, D. Meta-analytical comparison of voxel-based morphometry studies in obsessive-compulsive disorder vs other anxiety disorders. Arch Gen Psychiatry, 2010; 67: 701–11. • Rauch, SL, Whalen, PJ, Curran, T, Shin, LM, Coffey, BJ, Savage, CR, McInerney, SC, Baer, L, Jenike, MA.Probing striato-thalamic function in obsessive-compulsive disorder and Tourette syndrome using neuroimaging methods. Adv Neurol, 2001; 85: 207–24. • Real, E, Gratacòs, M, Labad, J, Alonso, P, Escaramís, G, Segalàs, C, Subirà, M, López-Solà, C, Estivill, X, Menchón, JM. Interaction of SLC1A1 gene variants and life stress on pharmacological resistance in obsessive compulsive disorder. Pharmacogenomics J, 2013; 13: 470–5. • Rosario-Campos, MC, Leckman, JF, Mercadante, MT, Shavitt, RG, Prado, HS, Sada, P, Zamignani,D, Miguel, EC. Adults with early-onset obsessive-compulsive disorder. Am J Psychiatry, 2001; 158: 1899–903. • Rosenberg, DR, Amponsah, A, Sullivan, A, MacMillan, S, Moore, GJ. Increased medial thalamiccho line in pediatric obsessive-compulsive disorder as detected by quantitative in vivo spectroscopic imaging. J Child Neurol, 2001; 16: 636–41. • Rosenberg, DR, Keshavan, MS. A. E. Bennett Research Award Toward a neurodevelopmental model of obsessive-compulsive disorder. Biol Psychiatry, 1998; 43:623–40. • Rosenberg, DR, MacMaster, FP, Keshavan, MS, Fitzgerald, KD, Stewart, CM, Moore, GJ. Decrease in caudate glutamatergic concentrations in pediatric obsessive-Compulsive disorder patients taking paroxetine. J Am Acad ChildAdolesc Psychiatry, 2000; 39: 1096–103. • Rosenberg, DR, Mirza, Y, Russell, A, Tang, J, Smith, JM, Banerjee, SP, Bhandari, R, Rose, M, Ivey, J, Boyd, C, Moore, GJ. Reduced anterior cingulated glutamatergic concentrations in childhood OCD and major depression versus healthy controls. J Am Acad ChildAdolesc Psychiatry, 2004; 43: 1146–53. • Rotge, J-Y, Guehl, D, Dilharreguy, B, Tignol, J, Bioulac, B, Allard, M, Burbaud, P, Aouizerate, B. Metaanalysis of brain volume changes in obsessive-compulsive disorder. Biol. Psychiatry, 2009; 65: 75–83. • Rotge, J-Y, Langbour, N, Guehl, D, Bioulac, B, Jaafari, N, Allard,M, Aouizerate, B, Burbaud, P. Gray matter alterations in obsessive-compulsive disorder: ananatomic likely hood estimation meta-analysis. Neuropsychopharmacology, 2010; 35: 686–91. • Rotge, JY, Clair, AH, Jaafari, N, Hantouche, E, Pelissolo, A, Goillandeau, M, Pochon, JB, Guehl, D, Bioulac, B, Burbaud, P, Tignol, J, Mallet, L, Aouizerate, B. A challenging Task for assessment of checking behaviors in obsessive-compulsive disorder. Acta Psychiatr Scand, 2008; 117: 465–73. • Ruscio, AM, Stein, DJ, Chiu, WT, Kessler, RC. The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication. Mol.Psychiatry, 2010; 15: 53–63. • Sampaio, AS, Fagerness, J, Crane, J, Leboyer, M, Delorme, R, Pauls, DL, Stewart, SE. Association between polymorphisms in GRIK2 geneandobsessivecompulsive disorder:a family-based study. CNS Neurosci.Ther, 2011.17,141–7. • Saxena, S, Brody, AL, Maidment, KM, Dunkin, JJ, Colgan, M, Alborzian, S, Phelps, ME, Baxter, LR. Localized orbitofrontal and subcortical metabolic changes and Predictors of response to paroxetine treatment in obsessive-compulsive disorder. Neuropsychopharmacology,1999; 21: 683–93. • Saxena, S, Rauch, SL. Functional neuroimaging and the neuroanatomy of obsessive-compulsive disorder. Psychiatr Clin NorthAm, 2000; 23: 563–86. • Sheehan, DV, Lecrubier, Y, Sheehan, KH, Amorim, P, Janavs, J, Weiller, E, Hergueta, T, Baker, R, Dunbar, GC. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation o fastructured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry, 1998; 59 Suppl2: 22– 33;quiz34–57. • Shepherd, JD, Huganir, RL. The cell biology of synaptic plasticity: AMPA receptor trafficking. Annu Rev Cell Dev Biol, 2007; 23: 613–43. • Sheppard, B, Chavira, D, Azzam, A, Grados, MA, Umaña, P, Garrido, H, Mathews, CA. ADHD prevalence and association with hoarding behaviors in childhoodonset OCD. Depress.Anxiety, 2010; 27: 667–74. • Silk, T, Chen, J, Seal, M, Vance, A. White matter abnormalities in pediatric obsessive-compulsive disorder. Psychiatry Res, 2013; 213: 154–60. • Smith, EA, Russell, A, Lorch, E, Banerjee, SP, Rose, M, Ivey, J, Bhandari, R, Moore, GJ, Rosenberg, DR. Increased medial thalamic choline found in pediatric patients with obsessive-compulsive disorder versus major depression or healthy control subjects: a magnetic resonance spectroscopy study. Biol Psychiatry, 2003; 54: 1399–405. • Starck, G, Ljungberg, M, Nilsson, M, Jönsson, L, Lundberg, S, Ivarsson, T, Ribbelin, S, Ekholm, S, Carlsson, A, Forssell-Aronsson, E, Carlsson, ML. A1H magnetic resonance spectroscopy study in adults with obsessive compulsive disorder: relationship between metabolite concentrations and symptom severity. J Neural Transm, 2008; 115: 1051–62. • Stern, L, Zohar, J, Cohen, R, Sasson, Y. Treatment of severe, drug resistant obsessive compulsive disorder with the 5HT1D agonist sumatriptan. Eur Neuropsychopharmacol, 1998; 8: 325–8. • Stewart, SE, Geller, DA, Jenike, M, Pauls, D, Shaw, D, Mullin, B, Faraone, SV. Long-term outcome of pediatric obsessive-compulsive disorder: a meta-analysis and qualitative review of the literature. Acta Psychiatr Scand, 2004; 110: 4–13. • Stewart, SE, Platko, J, Fagerness, J, Birns, J, Jenike, E, Smoller, JW, Perlis, R, Leboyer, M, Delorme, R, Chabane, N, Rauch, SL, Jenike, MA, Pauls, DL. A genetic family-based association study of OLIG2 in obsessive-compulsive disorder. Arch Gen Psychiatry, 2007; 64: 209–14. • Storch, EA, Lewin, AB, Larson, MJ, Geffken, GR, Murphy, TK, Geller, DA. Depression in youth with obsessive-compulsive disorder: clinical phenomenology and correlates. Psychiatry Res, 2012; 196: 83–9. • Storch, EA, Merlo, LJ, Larson, MJ., Geffken, GR, Lehmkuhl, HD, Jacob, ML, Murphy, TK, Goodman, WK. Impact of comorbidity on cognitive-behavioral therapy response in pediatric obsessive-compulsive disorder. J Am Acad ChildAdolesc Psychiatry, 2008; 47: 583–92. • Swedo, SE, Rapoport, JL, Leonard, H, Lenane, M, Cheslow, D. Obsessive-compulsive disorder in children and adolescents. Clinical phenomenology of 70 consecutive cases. Arch Gen Psychiatry, 1989a; 46: 335–41. • Swedo, SE, Schapiro, MB, Grady, CL, Cheslow, DL, Leonard, HL, Kumar, A, Friedland, R, Rapoport, SI, Rapoport, JL. Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder. Arch Gen Psychiatry, 1989b; 46: 518–23. • Szeszko, PR, Ardekani, BA, Ashtari, M, Malhotra, AK, Robinson, DG, Bilder, RM, Lim, KO. White matter abnormalities in obsessive-compulsive disorder: a diffusion tensor imaging study. Arch Gen Psychiatry, 2005; 62: 782–90. • Szeszko, PR, Christian, C, Macmaster, F, Lencz, T, Mirza,Y, Taormina, SP, Easter, P, Rose, M, Michalopoulou, GA, Rosenberg, DR. Gray matter structural alterations in psychotropic drug-naïve pediatric obsessive-compulsive disorder: an optimized voxelbased morphometry study. Am J Psychiatry, 2008; 165: 1299–307. • Szeszko, PR, MacMillan, S, McMeniman, M, Chen, S, Baribault, K, Lim, KO, Ivey, J, Rose, M, Banerjee, SP, Bhandari, R, Moore, GJ, Rosenberg, DR. Brain structural abnormalities in psychotropic drug-naïve pediatric patients with obsessive compulsive disorder. Am J Psychiatry, 2004; 161: 1049–56. • Taylor, S. Molecular genetics of obsessive-compulsive disorder: a comprehensive meta-analysis of genetic association studies. Mol Psychiatry, 2013; 18: 799– 805. • Taylor,S. Early versus late onset obsessive-compulsive disorder: evidence for distinct subtypes. Clin Psychol Rev, 2011; 31: 1083–100. • Taylor, S, Jang, KL, Asmundson, GJ. Etiology of obsessions and compulsions: a behavioral-genetic analysis. J Abnorm Psychol, 2010; 119: 672–82. • Thomsen, PH. Obsessive-compulsive disorders. Eur Child Adolesc Psychiatry, 2013; 22 Suppl 1: S23–8. • VanGrootheest, DS, Cath, DC, Beekman, AT, Boomsma, DI. Genetic and environmental influences on obsessive-compulsive symptoms in adults: a population-based twin-family study. Psychol Med, 2007; 37: 1635–44. • VanGrootheest, DS, Cath, DC, Beekman, AT, Boomsma, DI. Twin studies on obsessive-compulsive disorder: a review. Twin Res Hum Genet, 2005; 8: 450–8. • Villafuerte, SM, Vallabhaneni, K, Sliwerska, E, McMahon, FJ, Young, EA, Burmeister, M. SSRI response in depression may be influenced by SNPs in HTR1 Band HTR1A. Psychiatr Genet, 2009; 19: 281– 91. • Wanderer, S, Roessner, V, Freeman, R, Bock, N, Rothenberger, A, Becker, A relationship of obsessivecompulsive disorder to age-related comorbidity in children and adolescents with Tourette syndrome. J Dev Behav Pediatr, 2012; 33: 124–33. • Whiteside, SP, Port, JD, Deacon, BJ, Abramowitz, JS. A magnetic resonance spectroscopy investigation of obsessive-compulsive disorder and anxiety. Psychiatry Res, 2006; 146: 137–47. • Whiteside, SPH, Abramowitz, JS, Port, JD. The effect of behavior therapy on caudate N-acetyl-aspartic acid in adults with obsessive-compulsive disorder. Psychiatry Res, 2012; 201: 10–6. • Wu, H, Wang, X, Xiao, Z, Yu, S, Zhu, L, Wang, D, Jiang, K, Wang, Z, Zhang, T, Fralick, D. Association between SLC1A1 gene and early-onset OCD in the Han Chinese population: a case-control study. J Mol Neurosci, 2013; 50: 353–9. • Wu, K, Hanna, GL, Rosenberg, DR, Arnold, PD. The role of glutamate signaling in the pathogenesis and treatment of obsessive-compulsive disorder. Pharmacol Biochem Behav, 2012; 100: 726–35. • Xu, Z, Zhang, Z, Shi, Y, Pu, M, Yuan, Y, Zhang, X, Li, L, Reynolds, GP. Influence and Interaction of genetic polymorphisms in the serotonin system and life stress on antidepressant drug response. J Psychopharmacol, 2012; 26: 349–59. • Yücel, M, Harrison, BJ, Wood, SJ, Fornito, A, Wellard, RM, Pujol, J, Clarke, K, Phillips, ML, Kyrios, M, Velakoulis, D, Pantelis, C. Functional and biochemical alterations of the medial frontal cortex in obsessivecompulsive disorder. Arch Gen Psychiatry, 2007; 64: 946–55. • Yücel, M, Wood, SJ, Wellard, RM, Harrison, BJ, Fornito, A, Pujol, J, Velakoulis, D, Pantelis, C. Anterior cingulated glutamate-glutamine levels predict symptom severity in women with obsessive-compulsive disorder. Aust NZ J Psychiatry, 2008; 42: 467–77. 20 // EDITORIAL SCIENS

Biblioteca

Av. García del Río 2585 Piso 12 A - C.A.B.A
+54 11 2092 1646 | info@sciens.com.ar

Editorial Sciens, Todos los Derechos Reservados 2015